Fig. 4
From: Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
Neutralizing capacities of RBD-hAb-B22, -B23, -B25 and -B34 antibodies toward SARS-CoV-2 variant pseudoviruses. A Neutralization activities of RBD-hAb-B22, -B23, -B25 and -B34 against pseudoviruses of previous VOCs, including Alpha, Beta, Gamma and Delta (data are presented as mean ± SE). Representative data from two independent experiments are shown. B Neutralization activities of RBD-hAb-B22, -B23, -B25 and -B34 against pseudoviruses of different Omicron subvariants, BA.5, BQ.1.1, XBB.1, XBB.1.5, BF.7, BA.2.75.2, and CH.1.1 (data are presented as mean ± SE). Representative data from two independent experiments are shown